Ligand Pharmaceuticals Inc LGND
7 insiders sold $26.7M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $26.7M sold on 15 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Octavio Espinoza Chief Financial Officer |
- | $9.2M | Aug 12, 2026 |
| Andrew Reardon CLO & Secretary |
- | $8.7M | Nov 2, 2026 |
| Jason Haas Director |
- | $3.7M | Aug 12, 2026 |
| Jason Aryeh Director |
- | $3.0M | Nov 10, 2026 |
| John L. Lamattina Director |
- | $1.2M | Jun 10, 2026 |
| Stephen L. Sabba Director |
- | $545K | Jun 16, 2026 |
| Martine Zimmermann Director |
- | $342K | Sep 10, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 74 open-market sales by officers and directors, 16 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Jason Aryeh | Sale | -500 | 160K |
| Nov 10, 2026 | Jason Aryeh | Sale | -844 | 270K |
| Nov 10, 2026 | Jason Aryeh | Sale | -646 | 207K |
| Nov 10, 2026 | Jason Aryeh | Sale | -10 | 3K |
| Nov 10, 2026 | Jason Aryeh | Sale | -500 | 160K |
| Nov 10, 2026 | Jason Aryeh | Sale | -500 | 160K |
| Nov 4, 2026 | Jason Aryeh | Sale | -282 | 90K |
| Nov 2, 2026 | Jason Aryeh | Sale | -700 | 224K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -283 | 87K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -708 | 218K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -522 | 162K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -490 | 152K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -520 | 162K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -634 | 198K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -403 | 126K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -80 | 25K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -280 | 89K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -440 | 140K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -320 | 102K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -200 | 64K |
| Nov 2, 2026 | Andrew Reardon | Sale (10b5-1) | -120 | 39K |
| Oct 30, 2026 | Jason Aryeh | Sale | -50 | 16K |
| Oct 30, 2026 | Jason Aryeh | Sale | -50 | 16K |
| Oct 30, 2026 | Jason Aryeh | Sale | -52 | 17K |
| Oct 30, 2026 | Jason Aryeh | Sale | -1,209 | 387K |
| Oct 30, 2026 | Jason Aryeh | Sale | -50 | 16K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -833 | 252K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -1,976 | 600K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -1,535 | 467K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -404 | 124K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -235 | 72K |
| Oct 2, 2026 | Andrew Reardon | Sale (10b5-1) | -17 | 5K |
| Sep 10, 2026 | Martine Zimmermann | Sale | -1,200 | 342K |
| Sep 3, 2026 | Andrew Reardon | Sale (10b5-1) | -300 | 85K |
| Sep 3, 2026 | Andrew Reardon | Sale (10b5-1) | -1,800 | 513K |
| Sep 3, 2026 | Andrew Reardon | Sale (10b5-1) | -2,115 | 606K |
| Sep 3, 2026 | Andrew Reardon | Sale (10b5-1) | -385 | 111K |
| Sep 3, 2026 | Andrew Reardon | Sale (10b5-1) | -400 | 116K |
| Aug 12, 2026 | Jason Haas | Sale | -7,138 | 2.1M |
| Aug 12, 2026 | Octavio Espinoza | Sale (10b5-1) | -31,641 | 9.2M |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -105 | 30K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -33 | 9K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -157 | 45K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -1,032 | 296K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -1,214 | 349K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -356 | 103K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -503 | 146K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -200 | 58K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -991 | 289K |
| Aug 3, 2026 | Andrew Reardon | Sale (10b5-1) | -409 | 120K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -396 | 122K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -104 | 32K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -1,119 | 349K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -1,081 | 338K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -700 | 219K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -100 | 31K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -900 | 284K |
| Jul 1, 2026 | Andrew Reardon | Sale (10b5-1) | -600 | 190K |
| Jun 16, 2026 | Stephen L. Sabba | Sale | -2,145 | 545K |
| Jun 12, 2026 | Jason Haas | Sale | -3,000 | 765K |
| Jun 12, 2026 | Jason Haas | Sale | -3,461 | 886K |
| Jun 11, 2026 | Jason Aryeh | Sale | -4,500 | 1.1M |
| Jun 10, 2026 | John L. Lamattina | Sale | -257 | 64K |
| Jun 10, 2026 | John L. Lamattina | Sale | -232 | 58K |
| Jun 10, 2026 | John L. Lamattina | Sale | -697 | 174K |
| Jun 10, 2026 | John L. Lamattina | Sale | -3,405 | 857K |
| Jun 10, 2026 | Jason Aryeh | Sale | -500 | 125K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -491 | 110K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -677 | 152K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -1,432 | 324K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -400 | 91K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -584 | 133K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -1,216 | 279K |
| Jun 1, 2026 | Andrew Reardon | Sale (10b5-1) | -200 | 46K |
Show the other 59 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/LGND/export.csv") into a cell.